Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia

Leukemia

Volumn 10, Issue 2, 1996, Pages 213-224

  Raimondi, S C ^a,b   Pui, C H ^a,c   Hancock, M L ^a   Behm, F G ^a,b   Filatov, L ^a   Rivera, G K ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

51+; ALL

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 10; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME BANDING PATTERN; CHROMOSOME DUPLICATION; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; DIPLOIDY; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; ISOCHROMOSOME; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRISOMY; X CHROMOSOME;

EID: 0029940952     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Third International Workshop on Chromosomes in Leukaemia, 1980. Clinical significance of chromosomal abnormalities in acute lymphoblatic leukaemia. Cancer Genet Cytogenet 1981; 4: 111-137.
2. Williams DL et al. Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 1982; 60: 864-871.
3. Seeker-Walker LM et al. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. Br J Haematol 1989; 72: 336-342.
4. Bloomfield CD et al. Six-year follow-up of the significance of karyotype in acute lymphoblastic leukemia. From the Sixth International Workshop on Chromosomes in Leukemia 1987. Cancer Genet Cytogenet 1989; 40: 171-185.
5. Crist W et al. Current results of studies of immunophenotype-, age-and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia 1992; 6: 162-166.
6. Look AT et al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985; 65: 1079-1086.
7. Pui C-H et al. Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (>50 chromosomes) acute lymphoblastic leukemia. Blood 1989; 73: 1963-1967.
8. Trueworthy R et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in 8-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 1992; 10: 606-613.
9. Pui C-H, Raimondi SC, Williams DL. Isochromosome 17q in childhood acute lymphoblastic leukemia: an adverse cytogenetic feature in association with hyperdiploidy? Leukemia 1988; 2: 222-225.
10. Raimondi SC et al. Hyperdiploid (47-50) acute lymphoblastic leukemia in children. Blood 1992; 79: 3245-3252.
11. Harris MB et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Croup study. Blood 1992; 79: 3316-3324.
12. Rivera GK et al. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61-66.
13. Pui C-H et al. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude Total Therapy Study X. Leukemia 1992; 6: 150-157.
14. Pui C-H et al. Current treatment and results of St Jude studies for childhood acute lymphoblastic leukemia. In: Büchner T et al (eds). Acute Leukemias IV. Prognostic Factors and Treatment Strategies. Haematology and Blood Transfusion. Springer-Verlag: Berlin, Heidelberg, 1994, pp 307-313.
15. Bennett JC et al. The French-American-British (FAB) Cooperative Group: the morphologic classification of acute lymphoblastic leukemia: concordance among observers and clinical correlations. Br J Haematol 1981; 47: 553-561.
16. Pui C-H et al. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood 1990; 76: 590-596.
17. ISCN (1991). In: Mitelman F (ed). Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. Karger: Basel, 1991, pp 1-54.
18. Williams DL et al. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984; 13: 239-257.
19. Pui C-H, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343-362.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
21. Peto R et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
22. Mantel N, Haenszel W. The statistical aspects of the analysis of data arising from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
23. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237-2251.
24. Roberts WM et al. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Lancet 1994; 343: 331-332.
25. Pui C-H et al. Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. Blood 1992; 79: 2384-2391.
26. Onodera N, McCabe NR, Rubin CM. Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood 1992; 80: 203-208.
27. Dube ID, El-Sohl H. An apparent tandem quadruplication of chromosome 21 in a case of childhood acute lymphoblastic leukemia. Cancer Genet Cytogen 1986; 23: 253-256.
28. Liu Y et al. Multiple genetic events involving RBI gene deletion and amplification of chromosome 21 in a case of acute lymphocytic leukemia. Genes Chromosom Cancer 1994; 9: 72-75.
29. Whitehead WM et al. Accumulation of methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia. A pilot prognostic factor analysis. Blood 1990; 76: 44-49.
30. Whitehead VM, Vuchich MJ, Lauer SJ. Accumulation of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1992; 80: 1316-1323.
31. Synold T, Relling M, Boyett J. In vivo intracellular concentrations of methotrexate polyglutamates (MTX-PG) in acute lymphocytic leukemia (ALL) blasts from children randomized to receive either high-dose or low-dose methotrexate. Proc Am Soc Clin Oncol 1993; 12 (Suppl. 131): 325 (abstr.).
32. Kaspers GJL et al. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study. Blood 1995; 85: 751-756.
33. Campana D et al. Hyperdipioid acute lymphoblastic leukemia (ALL): a distinct biological entity with marked propensity to programmed cell death. Blood 1993; 82: (Suppl. 49) 185 (abstr.).
34. Catalog of Chromosome Aberrations in Cancer. 5th edn. Mitelman F (ed). Wiley-Liss: New York, 1994, pp 2797-2809.
35. Whitehead VM et al. Accumulation of methotrexate polyglutamates (MTX PGS) in lymphoblasts, ploidy and trisomy of both chromosomes 4 and 10 in childhood B-progenitor cell acute lymphoblastic leukemia (ALL): a Pediatric Oncology Group Study. Blood 1994; 84: 515 (abstr. 2046).